Healthcare newsletter

• InnoSkel appointed David Favre as CSO and Samantha Parker as CPAO
• Genespire appointed Jullianne Smith as CDO and Smaragda Angelidou as Head of CMC
• Helsinn appointed Mary Lynne Hedley to its Board of Directors
• Ergomed appointed Mark Enyedy as Non-Executive Director
• Indigo Diabetes appointed Paul Moraviec as Chairman of the Board
• Treeline Biosciences appointed Josh Bilenker as CEO and Jeff Engelman as CSO
• Genesis Therapeutics appointed Will McCarthy as CBO
• Medicenna Therapeutics appointed Kevin Moulder as CSO
• Surface Oncology appointed Henry Rath as CBO, Alison O’Neill as CMO and Jessica Fees as CFO
• Translate Bio appointed Brendan Smith as CFO, Greg Troiano as Chief Manufacturing Officer and Jim Sullivan as Senior Vice President, Pulmonary Discovery
• CohBar appointed Joseph Sarret as CEO
• Orasis Pharmaceuticals appointed Paul Smith as President and COO
• Triumvira appointed Teresa McRoberts as CFO and Andreas Bader as CSO
• Palantir appointed William Kassler as CMO
• KalVista Pharmaceuticals appointed Paul Audhya as CMO
• MOMA Therapeutics appointed Peter Hammerman as CSO
• Jaguar Gene Therapy appointed Joe McIntosh as CMO
• Eikon Therapeutics appointed Roger Perlmutter as CEO
• Guardant Health appointed Craig Eagle as CMO
• WindMIL Therapeutics appointed Kimberly Noonan as Executive Vice President, Chief Science and Technology Officer
• Verge Genomics appointed Robert Scannevin as CSO
• Redx Pharma appointed Peter Collum as CFO
• Carmine Therapeutics appointed Don Haut as CEO
• Cognito Therapeutics appointed Jonathan Lieber as CFO
• Shionogi appointed Nathan McCutcheon as COO
• VistaGen Therapeutics appointed Ann Cunningham as CCO
• Excision Bio appointed Christine Silverstein as CFO
• Escient Pharmaceuticals appointed Svetlana Makhni as CFO
• Synthekine appointed Naiyer Rizvi as CMO
• Centessa Pharmaceuticals appointed Antoine Yver as CMO
• LianBio appointed Yizhe Wang as CEO
• Acepodia appointed Thorsten Graef as CMO
• Attralus Therapeutics appointed Mark Timney as CEO, Gregory Bell as CMO and Glen Firestone as CBO
• Flagship Pioneering appointed Luisa Salter-Cid as CSO of Pioneering Medicines
• Dermavant appointed Michael Swartzburg as CFO
• Bantam Pharmaceutical appointed Michael Stocum as CEO
• Intrance Medical Systems appointed Patrick Shea as CEO
• Doximity appointed Anna Bryson as CFO
• Capsida appointed Swati Tole as CMO
• Pharvaris appointed Wim Souverijns as Chief Community and Engagement Officer
• Veracyte appointed Marc Stapley as CEO
• TellBio appointed Pritesh Gandhi as CEO and Annie Partisano as Senior Vice President and Head of Operations
• SCYNEXIS appointed Christine Coyne as CCO
• MapLight Therapeutic appointed Erin Pennock Foff as CMO
• Xalud Therapeutics appointed Howard Rutman as CDO, Brendan O’Leary as COO, Kristin Murray as Chief Regulatory Officer, Steve Vicik as CTO and Kristen Albright as Chief Commercial Development Lead
• Replimune appointed Tanya Lewis as Chief Development Operations Officer
• Heat Biologics appointed Anthony Manning as CSO
• Anthony Manning appointed Cokey Nguyen as CSO
• MANA Therapeutics appointed Arthur (Andy) Hurwitz as CSO
• Crescendo Biologics appointed Michael Booth as CFO
• Passage Bio appointed Eliseo Salinas as interim CMO
• Tevard Biosciences appointed Gopi Shanker as CSO
• Iovance appointed Frederick G. Vogt as interim President and CEO
• Blueprint Medicines appointed Percy Carter as CSO
• Medicenna appointed Mann Muhsin as CMO
• Experic appointed David Wood as Chairman and CEO
• NeuBase Therapeutics appointed Sandra Rojas-Caro as CMO
• Rain Therapeutics appointed Robert Doebele as President and CSO
• Fore Biotherapeutics appointed Stacie Peacock Shepherd as CMO and Nora Brennan as CFO
• Cybrexa Therapeutics appointed Stephen Basso as CFO
• Celularity appointed Bradley Glover as EVP and CTO
• Aerovate Therapeutics appointed Timothy Noyes as CEO
• Cognito Therapeutics appointed Everett Crosland as CCO
• Umoja Biopharma appointed Irena Melnikova as CFO
• ONI appointed Tyler Ralston as CTO
• AavantiBio appointed Jessie Hanrahan as Chief Regulatory Officer

Company Name	Amount Raised	Type of Fundraise	Country	Date
Public company financings
Valneva	$107.6 million	IPO	France	11-May-21
Vaccitech	$110.5 million	IPO	UK	4-May-21
COMPASS Pathways	$165.6 million	Public Offering	US	30-April-21
Private company Financings
Eliem Therapeutics	$60 million	Series B	UK	25-May-21
Numab	$110.8 million	Series C	Switzerland	20-May-21
BioTheryX Inc.	$92 million	Series E	US	20-May-21
RenBio	$24 million	Series A	US	20-May-21
Duality Biologics	$90 million	Series B	China	20-May-21
Vedere Bio II Inc.	$77 million	Series A	US	19-May-21
Interius Biotherapeutics	$96 million	Series A	US	19-May-21
PathAI Inc.	$165 million	Series C	US	19-May-21
Hummingbird Bioscience	$125 million	Series C	US	18-May-21
eureKARE	$60 million	Series A	France	18-May-21
Phico Therapeutics Ltd.	$9.9 million	Undisclosed	UK	12-May-21
Laevoroc Oncology	$1.1 million	Seed	Switzerland	12-May-21
Adaptive Phage Therapeutics Inc.	$40.8 million	Series B	US	12-May-21
Nuvalent Inc.	$135 million	Series B	US	12-May-21
CB Therapeutics	Undisclosed	Series A	US	11-May-21
Therini Bio Inc.	$26.4 million	Seed	US	11-May-21
Gennao Bio	$40 million	Series A	US	11-May-21
Alebund Pharmaceuticals	$60 million	Series B	China	11-May-21
Dyno Therapeutics	$100 million	Series A	US	7-May-21
Oxford Nanopore Technologies Ltd.	$269.8 million	Crossover	UK	5-May-21
Oculis S.A.	$57 million	Series C	Switzerland	5-May-21
Aceragen Inc.	$35 million	Seed	Switzerland	5-May-21
Cumulus Neuroscience	$8.5 million	Undisclosed	UK	5-May-21
RNAimmune Inc.	$10 million	Seed	US	4-May-21
Adcendo	$62 million	Series A	Denmark	30-Apr-21
Ultivue Inc.	$50 million	Series D	US	28-Apr-21
Arch Oncology	$105 million	Series C	US	27-Apr- 21

Bank	Analyst
ABG Sundal Collier	Morten Larsen, Daniel Thorsson
ABN AMRO	Mark van der Geest, Rene Verhoeff
Alm. Brand Markets	Michael Friis Jørgensen
AlphaValue	Armelle Moulin, Marion Scherzinger
Banco de Sabadell, S.A.	Javier Esteban
Banco Espirito Santo de Investimento	Luis Navia
Bank am Bellevue	Bruno Eschli, Stephen Leventhal
Bankhaus Lampe KG	Heiko Feber, Frank Neumann
Bank Vontobel AG	Carla Baenziger
Barclays	Hassan Al-Wakeel, Blanka Porkolab, Emily Field, Jameel Bakhsh, Brian Balchin, Peter Lawson
Berenberg Bank	Scott Bardo, Luisa Hector, Kerry Holford, Tom Jones, Ravi Misra, Xian Deng, Michael Healy, Esther Hong, Iris Zhilin Long, Zhiqiang Shu, Yun Zhong (David Hogg), Eoghan Reid
Bank of America Merrill Lynch	Aspen Mori (NY), Graham Parry (London), Qian Weng, John Aldersley (Dan Lundquist)
Bryan, Garnier & Co	Dylan van Haaften, Eric Le Berrigaud, Olga Smolentseva, Victor Floc’h, Jean Jacques Le Fur, (Dominic Wilson)
CA Cheuvreux	Marcel Brand, Laurent Flamme, Richard Koch, Oliver Reinberg
Caja Madrid Bolsa	Ana Isabel González García
Carnegie Bank	Niels Granholm, Philip Lagnetoft, Kristofer Liljeberg-Svensson, Carsten Lonborg Madsen, Henrik Sinding, Lars Topholm
Cenkos Securities	Chris Donnellan
Citigroup	Liav Abraham (US), Andrew Baum, Alex Glasner, Peter Verdult, Patrick Wood, (David Rawley)
CM-CIC Securities	Agnès Blazy, Arsene Guekam
Commerzbank	Volker Braun, Daniel Wendorff
Cowen International	David Kirkpatrick, Ritu Baral, Ryan Blicker, Ken Cacciatore, Marc Frahm, Joshua Jennings, Chris Lin, Charles Rhyee, Doug Schenkel, Yaron Weber
Credit Suisse	Christoph Gretler, Evan Seigerman, Matt Miksic Barbora Blaha, Jo Walton, Matthew Weston, (Phil Gestrin)
Danske Equities	Thomas Bowers, Mattias Häggblom, Hans Jeppsson, Martin Parkhøi, Søren Samsøe
Deutsche Bank	Emmanuel Papadakis, Rajan Sharma, Justin Bowers, Jack McKibben, Farzana Habib, Katie Kraft, Jeremy Finkelstein, Andrew Vincent
Degroof Petercam	Thomas Guillot, Benoit Louage, Chris Keepers
DnB NOR	Rune Dahl
DZ Bank	Christa Bähr, Elmar Kraus, Thomas Maul, Peter Spengler
Edison	John Priestner, Susie Jana, John Savin, Jonas Peciulis, Sean Conroy, Maxim Jacobs, Nathaniel Calloway , Pooya Hemami
Equinet Institutional Services	Edouard Aubery
Equity Development	Emma Ulker
Exane BNP Paribas	Richard Parkes, Alex Evans, Julien Dormois, Hugo Solvet, Nicolas Langlet, Kartik Swaminathan
fairesearch GmhH & Co	Martin Schnee
finnCap	Mark Brewer, Arshad Ahad, Nik Lysiuk
Goetz Partners	Melina Reisenberg, Chris Redhead
Goldman Sachs	Krishna-Chaitanya Arikatla, Veronika Dubajova, Divya Harikesh, Keyur Parekh, Graig Suvannavejh, Joanna Tucka, Kira Huppertz
Handelsbanken Capital Markets	Klaus Madsen, Björn Olander, Peter Sehested
Hardman and Co	Martin Hall, Gregoire Pave
Houlihan Lokey	Paul Tomasic, Andrew Murray-Lyon
HSBC	Steve McGarry, Julie Mead, Lucy Acton, Murielle André-Pinard
ING	Sjoerd Ummels, David Vagman
Intermediate Capital Group	Allan Marchington, Toby Sykes, Peter Kiener, Tracy Weightman, Peter Kiener
Investec	Andrew Whitney, Jens Lindqvist, (Brough Ransom)
Jefferies	Harry Sephton, Grace Lee, Lucy Codrington, Philippa Gardner, Kit Lee, Ken Rumph, James Vane-Tempest, Peter Welford, Ing Shen Tan, Erin Primdahl, (Jan Scherer)
JP Morgan Cazenove	David Adlington, Alex Comer, James Gordon, Richard Vosser, Marjan Daeipour
KBC Securities	Sandra Cauwenberghs, Lenny Van Steenhuyse
Kempen & Co	Alexander Cogut, Rene Wouters, Suzanne van Voorthuizen, Ingrid Gafanhão, Sebastiaan van der Schoot
Kepler Capital Markets	Arsene Gekam, Damien Choplain, David Evans, Maja Pataki, Martin Voegtli,  Matthias Maenhaut
Landesbank Baden-Wuerttemberg	Timo Kuerschner
Liberum Capital	Alistair Campbell, Graham Doyle
Morgan Stanley	Alex Gibson, Michael Jungling, Simon Mather, Jenny Leeds, Cailin McGurk
N+1 Singer	Chris Glasper, Edward Thomason, Sahill Shan
Natixis Beatrice	Philipe Lanone, Jean-Jacques  Le Fur
Nordea Markets	Klas Pyk
Nord/LB	Holger Fechner, Thorsten Strauss
Numis	Paul Cuddon, Stefan Hamill, (Ceri Morgan)
Oddo Securities	Martial Descoutures, Oussama Denguir
Panmure Gordon	Mike Mitchell, Julie Simmonds, (David Cox)
Pareto Securities	Finlay Heppenstall, Ulrik Trattner
Peel Hunt	Miles Dixon, Anchal Verma, Amy Walker
Portzamparc Gestion S.A.	Christophe Dombu
RBC Capital Markets	Zoe Karamanoli (maternity), Charles Weston, Jack Reynolds-Clarke
Redburn	Simon Baker, Darshan R., Issie Kirby, Charles Pitman, Robert Shore, Ed Ridley-Day
Rx Securities	Samir Devani, Joseph Hedden, Michael King, Ross Blair
Sanford C Bernstein	Lisa Clive
Santander	Rebecca McClellan, Alejandro Conde Fraisolí, Tomasz Krukowski,
SEB Enskilda	Lars Hevreng, Henrik Simonsen, Peder Strand
Shore Capital	Adam Barker, Tara Raveendran
Société Générale	Florent Cespedes, Patrick Jousseaume, Delphine Le Louët, Justin Smith
Standard & Poors	Sho Matsubara, Jacob Thrane
Stifel	Christian Glennie, Max Herrmann, James Osborne (Erland Sternby)
Swedbank	Johan Unnerus
Trinity Delta	Lala Gregorek, Franc Gregori
UBS	Laura Sutcliffe, Michael Leuchten, Jack Scannell, Sebastien Walker
Zürcher Kantonalbank	Michael Nawrath

InnoSkel appointed David Favre as CSO and Samantha Parker as CPAO

Genespire appointed Jullianne Smith as CDO and Smaragda Angelidou as Head of CMC

Helsinn appointed Mary Lynne Hedley to its Board of Directors

Ergomed appointed Mark Enyedy as Non-Executive Director

Indigo Diabetes appointed Paul Moraviec as Chairman of the Board

Treeline Biosciences appointed Josh Bilenker as CEO and Jeff Engelman as CSO

Genesis Therapeutics appointed Will McCarthy as CBO

Medicenna Therapeutics appointed Kevin Moulder as CSO

Surface Oncology appointed Henry Rath as CBO, Alison O’Neill as CMO and Jessica Fees as CFO

Translate Bio appointed Brendan Smith as CFO, Greg Troiano as Chief Manufacturing Officer and Jim Sullivan as Senior Vice President, Pulmonary Discovery

CohBar appointed Joseph Sarret as CEO

Orasis Pharmaceuticals appointed Paul Smith as President and COO

Triumvira appointed Teresa McRoberts as CFO and Andreas Bader as CSO

Palantir appointed William Kassler as CMO

KalVista Pharmaceuticals appointed Paul Audhya as CMO

MOMA Therapeutics appointed Peter Hammerman as CSO

Jaguar Gene Therapy appointed Joe McIntosh as CMO

Eikon Therapeutics appointed Roger Perlmutter as CEO

Guardant Health appointed Craig Eagle as CMO

WindMIL Therapeutics appointed Kimberly Noonan as Executive Vice President, Chief Science and Technology Officer

Verge Genomics appointed Robert Scannevin as CSO

Redx Pharma appointed Peter Collum as CFO

Carmine Therapeutics appointed Don Haut as CEO

Cognito Therapeutics appointed Jonathan Lieber as CFO

Shionogi appointed Nathan McCutcheon as COO

VistaGen Therapeutics appointed Ann Cunningham as CCO

Excision Bio appointed Christine Silverstein as CFO

Escient Pharmaceuticals appointed Svetlana Makhni as CFO

Synthekine appointed Naiyer Rizvi as CMO

Centessa Pharmaceuticals appointed Antoine Yver as CMO

LianBio appointed Yizhe Wang as CEO

Acepodia appointed Thorsten Graef as CMO

Attralus Therapeutics appointed Mark Timney as CEO, Gregory Bell as CMO and Glen Firestone as CBO

Flagship Pioneering appointed Luisa Salter-Cid as CSO of Pioneering Medicines

Dermavant appointed Michael Swartzburg as CFO

Bantam Pharmaceutical appointed Michael Stocum as CEO

Intrance Medical Systems appointed Patrick Shea as CEO

Doximity appointed Anna Bryson as CFO

Capsida appointed Swati Tole as CMO

Pharvaris appointed Wim Souverijns as Chief Community and Engagement Officer

Veracyte appointed Marc Stapley as CEO

TellBio appointed Pritesh Gandhi as CEO and Annie Partisano as Senior Vice President and Head of Operations

SCYNEXIS appointed Christine Coyne as CCO

MapLight Therapeutic appointed Erin Pennock Foff as CMO

Xalud Therapeutics appointed Howard Rutman as CDO, Brendan O’Leary as COO, Kristin Murray as Chief Regulatory Officer, Steve Vicik as CTO and Kristen Albright as Chief Commercial Development Lead

Replimune appointed Tanya Lewis as Chief Development Operations Officer

Heat Biologics appointed Anthony Manning as CSO

Anthony Manning appointed Cokey Nguyen as CSO

MANA Therapeutics appointed Arthur (Andy) Hurwitz as CSO

Crescendo Biologics appointed Michael Booth as CFO

Passage Bio appointed Eliseo Salinas as interim CMO

Tevard Biosciences appointed Gopi Shanker as CSO

Iovance appointed Frederick G. Vogt as interim President and CEO

Blueprint Medicines appointed Percy Carter as CSO

Medicenna appointed Mann Muhsin as CMO

Experic appointed David Wood as Chairman and CEO

NeuBase Therapeutics appointed Sandra Rojas-Caro as CMO

Rain Therapeutics appointed Robert Doebele as President and CSO

Fore Biotherapeutics appointed Stacie Peacock Shepherd as CMO and Nora Brennan as CFO

Cybrexa Therapeutics appointed Stephen Basso as CFO

Celularity appointed Bradley Glover as EVP and CTO

Aerovate Therapeutics appointed Timothy Noyes as CEO

Cognito Therapeutics appointed Everett Crosland as CCO

Umoja Biopharma appointed Irena Melnikova as CFO

ONI appointed Tyler Ralston as CTO

AavantiBio appointed Jessie Hanrahan as Chief Regulatory Officer